13D/13G Filings - Silence Therapeutics plc (SLN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-31
10:50 am
Purchase
2025-03-3113DSilence Therapeutics plc
SLN
Griffiths Richard Ian29,283,897
20.700%
2,017,896increase
(+7.40%)
Filing
History
2025-02-14
8:03 pm
Purchase
2024-12-3113GSilence Therapeutics plc
SLN
Redmile Group LLC7,197,951
5.100%
7,197,951increase
(New Position)
Filing
History
2025-02-11
6:41 pm
Purchase
2024-12-3113GSilence Therapeutics plc
SLN
Lombard Odier Asset Management (USA) Corp10,713,627
7.600%
2,721,396increase
(+34.05%)
Filing
History
2024-12-20
5:32 pm
Purchase
2024-12-1813DSilence Therapeutics plc
SLN
Griffiths Richard Ian27,266,001
19.300%
3,556,899increase
(+15.00%)
Filing
History
2024-11-14
1:13 pm
Sale
2024-09-3013GSilence Therapeutics plc
SLN
Lombard Odier Asset Management (USA) Corp7,992,231
5.700%
-3,645,288decrease
(-31.32%)
Filing
History
2024-11-14
09:44 am
Sale
2024-09-3013GSilence Therapeutics plc
SLN
Deep Track Capital LP3,000,000
2.140%
-2,854,740decrease
(-48.76%)
Filing
History
2024-11-12
4:31 pm
Purchase
2024-09-3013GSilence Therapeutics plc
SLN
Invus Public Equities, L.P.8,495,310
6.100%
156,453increase
(+1.88%)
Filing
History
2024-08-02
6:51 pm
Purchase
2024-07-2513GSilence Therapeutics plc
SLN
Invus Public Equities, L.P.8,338,857
6.000%
8,338,857increase
(New Position)
Filing
History
2024-03-27
5:07 pm
Sale
2024-03-2713DSilence Therapeutics plc
SLN
Griffiths Richard Ian23,709,102
16.900%
-5,013,153decrease
(-17.45%)
Filing
History
2024-02-14
09:54 am
Purchase
2023-12-3113GSilence Therapeutics plc
SLN
Lombard Odier Asset Management (USA) Corp11,637,519
10.400%
10,317increase
(+0.09%)
Filing
History
2024-02-14
08:55 am
Unchanged
2023-12-3113GSilence Therapeutics plc
SLN
Deep Track Capital LP5,854,740
5.430%
0
(Unchanged)
Filing
History
2024-02-12
6:15 pm
Sale
2023-12-2913GSilence Therapeutics plc
SLN
GOLDMAN SACHS GROUP INC
GS
2,316,169
2.200%
-2,224,994decrease
(-49.00%)
Filing
History
2024-02-09
5:05 pm
Purchase
2023-12-3113GSilence Therapeutics plc
SLN
Artal International S.C.A.9,000,000
7.800%
1,500,000increase
(+20.00%)
Filing
History
2023-09-01
4:12 pm
Purchase
2023-08-2413GSilence Therapeutics plc
SLN
Artal International S.C.A.7,500,000
6.800%
7,500,000increase
(New Position)
Filing
History
2023-08-14
5:01 pm
Purchase
2023-08-1413DSilence Therapeutics plc
SLN
Griffiths Richard Ian28,722,255
26.580%
1,348,863increase
(+4.93%)
Filing
History
2023-02-14
2:23 pm
Purchase
2022-12-3113GSilence Therapeutics plc
SLN
TCG Crossover GP I, LLC6,314,625
5.900%
6,314,625increase
(New Position)
Filing
History
2023-02-14
10:45 am
Purchase
2022-12-3113GSilence Therapeutics plc
SLN
Lombard Odier Asset Management (USA) Corp11,627,202
10.800%
1,209,639increase
(+11.61%)
Filing
History
2023-02-08
3:09 pm
Purchase
2022-12-3013GSilence Therapeutics plc
SLN
GOLDMAN SACHS GROUP INC
GS
4,541,163
5.100%
4,541,163increase
(New Position)
Filing
History
2022-10-20
4:01 pm
Purchase
2022-08-1613DSilence Therapeutics plc
SLN
Griffiths Richard Ian27,373,392
25.420%
1,904,121increase
(+7.48%)
Filing
History
2022-08-22
4:13 pm
Purchase
2022-08-1213GSilence Therapeutics plc
SLN
Deep Track Capital LP5,854,740
5.440%
5,854,740increase
(New Position)
Filing
History
Goto 0, 1, Next